Interestingly, the activation of GSK3β is also implicated in amyloidogenesis by inhibiting the secretory cleavage of APP, increasing the production of Aβ and leading to memory impairment in animal models (Forlenza et al., 2011). The gene discussed is GSK3B; the disease is memory impairment.